OptimOva is a patented blood test method developed at Oslo University Hospital. The test personalises hormone dosing by fine-tuning the routine dosing standard and adjusting the prescribed dose to the patient’s needs. The objective of this novel test is to optimise egg production, thus increasing the chances for having enough good quality embryos and ultimately improving chances for pregnancy and live birth delivery. In addition, excess good quality embryos are cryopreserved for future cycles, eliminating the need for further hormonal treatment.
Company’s Keywords:
personalize medicine, medical diagnostics, infertility, startup, in vitro fertilisation, heathcare, medical science
<3
<
<2018
Your request has been submitted successfully.
Own or work here?